Evidence map›Paper›PMID 40591933›Full record

ArticleHuman reproduction (Oxford, England)2025

CCDC89 is required for optimal sperm motility and male fertility in mammals.

Moira K O'Bryan, Gülizar Saritas, Joseph Nguyen, Sofia B Winge, Anne E O'Connor, Helen Castillo-Madeen, Donald F Conrad, Maddison Graffeo, Reza Nosrati, Jessica E M Dunleavy and 2 more

Abstract read
In one paragraph

Article in Human reproduction (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. A novel hsa_circ_0070963/miR-223-3p/International journal of reproductive biomedicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Moira K O'BryanSchool of BioSciences and Bio21 Molecular Sciences and Biotechnology Institute, The University of Melbourne, Parkville, Australia.ORCID 0000-0001-7298-4940
Gülizar SaritasDepartment of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
Joseph NguyenSchool of BioSciences and Bio21 Molecular Sciences and Biotechnology Institute, The University of Melbourne, Parkville, Australia.
Sofia B WingeDepartment of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
Anne E O'ConnorSchool of BioSciences and Bio21 Molecular Sciences and Biotechnology Institute, The University of Melbourne, Parkville, Australia.
Helen Castillo-MadeenOregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR, USA.
Donald F ConradInternational Male Infertility Genomics Consortium, IMIGC.ORCID 0000-0003-3828-8970
Maddison GraffeoSchool of BioSciences and Bio21 Molecular Sciences and Biotechnology Institute, The University of Melbourne, Parkville, Australia.
Reza NosratiDepartment of Mechanical and Aerospace Engineering, Monash University, Clayton, VIC, Australia.
Jessica E M DunleavySchool of BioSciences and Bio21 Molecular Sciences and Biotechnology Institute, The University of Melbourne, Parkville, Australia.
Kristian AlmstrupInternational Male Infertility Genomics Consortium, IMIGC.ORCID 0000-0002-1832-0307
Brendan J HoustonSchool of BioSciences and Bio21 Molecular Sciences and Biotechnology Institute, The University of Melbourne, Parkville, Australia.ORCID 0000-0002-1078-756X

Funding

Project IIIP50HD096723 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI John C Schimenti · 2019 to 2026
$15.0M
GENOMICS OF SPERMATOGENIC IMPAIRMENTR01HD078641 · NICHD · WASHINGTON UNIVERSITY · PI Kenneth Ivan Aston, DONALD F. CONRAD · 2014 to 2026
$6.3M
Independent Research Fund 1030-00381BNational Health and Medical Research Council APP1120356NICHD NIH HHS P50 HD096723NICHD NIH HHS R01 HD078641NIH HHS P50HD096723NIH HHS R01HD078641Novo Nordisk Foundation NNF210C0069913Novo Nordisk Foundation NNF21C0069969
6 · The paper itself

Abstract

study questionWhat is the role of coiled-coil domain-containing protein 89 (CCDC89) in mammalian male fertility? SUMMARY ANSWER: The presence of CCDC89 is required for normal sperm motility and therefore optimal male fertility in mice, while CCDC89 variants affected spermatogenesis in both mice and humans. WHAT IS KNOWN ALREADY: Coiled-coiled domain-containing proteins play a variety of roles in biological processes, including cell division, the production of motile sperm, and the regulation of their motility. STUDY DESIGN, SIZE, DURATION: DNA from infertile men with azoospermia was sequenced to identify genetic variants as per the Genetics of Male Infertility Initiative (GEMINI) study. Genetic variants were identified in CCDC89 in three men, by whole exome sequencing. A testis biopsy from infertile Patient 1 (CCDC89 variant c. G903T) was available and used to inspect tissue pathology. Ccdc89 knockout (Ccdc89-/-) and Ccdc89E297D/E297D mutant mouse models were generated to define the role of CCDC89 in male fertility and the role of the specific CCDC89 genetic variant, c. G903T, in the pathogenesis of infertility. PARTICIPANTS/MATERIALS, SETTING,

methodsCCDC89 RNA expression and protein localization were investigated in a testis biopsy from a control male with normal spermatogenesis. Male fertility of the mutant mouse lines was assessed via breeding, histology, daily sperm production, electron microscopy, computer-assisted and high-speed sperm motility analysis, and in vitro fertilization. MAIN RESULTS AND THE ROLE OF CHANCE: Ccdc89-/- male mice were sub-fertile, with impaired progressive sperm motility and curvilinear velocity due to a rigid sperm tail midpiece without any overt structural defects. While Ccdc89E297D/E297D males were fertile, their testis weights and germ cell content were reduced, suggesting a potential role of the c. G903T variant, observed in each of the two men, in the pathogenesis of their spermatogenic impairment. We also identified a new genetic variant in CCDC89 (c.G1024A) in another infertile man, that was in trans with the c. G903T genetic variant. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: The identification of additional infertile men with genetic variants in CCDC89, and quality clinical data, are required to determine prognostic reliability regarding CCDC89 variants. There are likely to be species-specific differences in gene function. WIDER IMPLICATIONS OF THE

findingsOur data highlight a role for CCDC89, in regulating the sperm tail waveform, that is required for optimal sperm fertilization capacity and male fertility. We highlight CCDC89 as a regulator of male fertility in mammals, where variants in CCDC89 can affect spermatogenesis and may be a risk factor for human male infertility. This study underscores the importance of validating clinical genetic findings. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by a National Health and Medical Research Council grant (APP1120356), National Institutes of Health grants (R01HD078641 and P50HD096723), the Novo Nordisk Foundation (grant numbers NNF210C0069913 and NNF21C0069969), the Capital Region of Denmark, the Independent Research Fund (grant number: 1030-00381B), and the Svend Andersen Foundation (grant number: 84-A.08), and the Christian and Ottilia Brorsons (No. 12038-1) and Frimodt-Heineke Foundation travel grants for research exchange. The authors have no conflicts of interest.

Indexed as

AzoospermiaFertilityInfertility, MaleSperm MotilityAnimalsHumansMaleMiceMice, KnockoutSpermatogenesisSpermatozoaTestisCCDC89genetic variantsmale infertilityspermatogenesissperm functionsperm motility

Identifiers

PMID40591933
PMCPMC12548035

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.